InfanDx AG Revises Strategy and Broadens Diagnostics Pipeline for Child Health
March 28, 2023 04:00 ET
|
AKAMPION
After promising top-line data for metabolic biomarkers, in-depth data analysis revealed BANON study results not generalizable to HIE patients in clinical routine.Development of HypoxE® test based...
Thermosome Receives Regulatory Approval for First-In-Human Trial with its Lead Program THE001
March 28, 2023 03:45 ET
|
AKAMPION
- Novel compound for targeted tumor therapy to be evaluated in patients with soft tissue sarcoma- First patients to be enrolled in Q2, 2023 Munich, Germany – March 28, 2023 – Thermosome, a...
HpVac reports positive effects of its lead compound HpVac-R13 in a murine model of allergic asthma following oral administration
March 27, 2023 04:00 ET
|
AKAMPION
- Study results indicate beneficial effects on airway hyperresponsiveness, remodeling and inflammation Geneva, Switzerland, March 27, 2023 – HpVac SA, a company developing novel preventive and...
Dopavision Appoints Prof. Dr. Jens Ellrich as Chief Scientific Officer
March 21, 2023 05:00 ET
|
AKAMPION
- Leading translational medicine and neuroscience expert to head Dopavision’s research activities Berlin, Germany, March 21, 2023 --- Dopavision, a clinical-stage company pioneering the...
Cellbox Solutions Raises EUR 6.5 Million in Series A1 Financing Round
March 07, 2023 04:00 ET
|
AKAMPION
- CK Ventures, Fraunhofer Ventures, NRW.Venture and Fil Bros join forces with renowned private investors- Planned expansion of US business and launch of tailored cell therapy shipment solutions ...
Evonik and BellaSeno advance commercialization of 3D-printed, bioresorbable implants
March 06, 2023 04:00 ET
|
AKAMPION
Expanded partnership of two leading innovatorsResomer® used in commercial 3D-printed implants for both soft and hard tissue applicationsBellaSeno receives market authorization for fully resorbable...
Pan Cancer T Appoints Prof. Dr. Chiara Bonini to its Scientific Advisory Board
February 23, 2023 04:00 ET
|
AKAMPION
- Leading European T cell therapy researcher adds further scientific expertise ROTTERDAM, February 23, 2023 - Pan Cancer T B.V., a biotech spin-off from Erasmus MC dedicated to the discovery...
Rewind Therapeutics Raises Additional Funding and Adds Sunstone Life Science Ventures A/S as New Investor
January 25, 2023 04:00 ET
|
AKAMPION
- Claus Andersson, PhD, joins Rewind´s Board of Directors Leuven, Belgium, January 25, 2023 --- Rewind Therapeutics, a company developing first-in-class treatments for demyelination-associated...
ImmunOs Therapeutics Receives Regulatory Approval for First-In-Human Trial of IOS-1002
January 17, 2023 04:00 ET
|
AKAMPION
- Lead compound IOS-1002 to be studied as mono and combination therapy in patients with advanced solid tumors- First patients to be enrolled in Q1, 2023 Schlieren (Zurich Area), Switzerland –...
Pan Cancer T Appoints Dr. Rachel Abbott as Chief Scientific Officer
January 17, 2023 04:00 ET
|
AKAMPION
- Strengthening of T cell research expertise to develop next-generation T cell therapies for patients with limited or no treatment options ROTTERDAM, January 17, 2023 - Pan Cancer T B.V., a...